Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $93.6B |
| FY2017, ended Dec 31, 2017 | $93.8B |
| FY2018, ended Dec 31, 2018 | $79.8B |
| FY2019, ended Dec 31, 2019 | $82.1B |
| FY2020, ended Dec 31, 2020 | $73.2B |
| FY2021, ended Dec 31, 2021 | $91.0B |
| FY2022, ended Dec 31, 2022 | $107B |
| FY2023, ended Dec 31, 2023 | $101B |
| FY2024, ended Dec 31, 2024 | $115B |
| FY2025, ended Dec 31, 2025 | $152B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $157B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.4B |
| FY2017, ended Dec 31, 2017 | $26.1B |
| FY2018, ended Dec 31, 2018 | $22.1B |
| FY2019, ended Dec 31, 2019 | $22.4B |
| FY2020, ended Dec 31, 2020 | $24.7B |
| FY2021, ended Dec 31, 2021 | $27.3B |
| FY2022, ended Dec 31, 2022 | $27.3B |
| FY2023, ended Dec 31, 2023 | $27.1B |
| FY2024, ended Dec 31, 2024 | $28.8B |
| FY2025, ended Dec 31, 2025 | $29.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $30.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $13.5B | $16.3B |
| FY2017, ended Dec 31, 2017 | $4.63B | $11.3B |
| FY2018, ended Dec 31, 2018 | $5.46B | $7.48B |
| FY2019, ended Dec 31, 2019 | $5.39B | $8.32B |
| FY2020, ended Dec 31, 2020 | $123M | $7.52B |
| FY2021, ended Dec 31, 2021 | $6.22B | $10.8B |
| FY2022, ended Dec 31, 2022 | $4.59B | $8.34B |
| FY2023, ended Dec 31, 2023 | $5.67B | $7.42B |
| FY2024, ended Dec 31, 2024 | $480M | $10.3B |
| FY2025, ended Dec 31, 2025 | $8.51B | $9.46B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$3.24B | $12.9B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.23B |
| FY2017, ended Dec 31, 2017 | $7.59B |
| FY2018, ended Dec 31, 2018 | $17.9B |
| FY2019, ended Dec 31, 2019 | $11.6B |
| FY2020, ended Dec 31, 2020 | $6.00B |
| FY2021, ended Dec 31, 2021 | $5.34B |
| FY2022, ended Dec 31, 2022 | $5.41B |
| FY2023, ended Dec 31, 2023 | $6.08B |
| FY2024, ended Dec 31, 2024 | $9.99B |
| FY2025, ended Dec 31, 2025 | $7.56B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.18B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $26.3B |
| FY2017, ended Dec 31, 2017 | $33.5B |
| FY2018, ended Dec 31, 2018 | $27.3B |
| FY2019, ended Dec 31, 2019 | $24.6B |
| FY2020, ended Dec 31, 2020 | $31.4B |
| FY2021, ended Dec 31, 2021 | $26.7B |
| FY2022, ended Dec 31, 2022 | $25.2B |
| FY2023, ended Dec 31, 2023 | $25.0B |
| FY2024, ended Dec 31, 2024 | $26.7B |
| FY2025, ended Dec 31, 2025 | $24.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $26.2B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.31B |
| FY2017, ended Dec 31, 2017 | 1.31B |
| FY2018, ended Dec 31, 2018 | 1.28B |
| FY2019, ended Dec 31, 2019 | 1.26B |
| FY2020, ended Dec 31, 2020 | 1.26B |
| FY2021, ended Dec 31, 2021 | 1.25B |
| FY2022, ended Dec 31, 2022 | 1.25B |
| FY2023, ended Dec 31, 2023 | 1.25B |
| FY2024, ended Dec 31, 2024 | 1.25B |
| FY2025, ended Dec 31, 2025 | 1.24B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.24B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $11.0B | $380M | $208M |
| FY2017, ended Dec 31, 2017 | $954M | $638M | $234M |
| FY2018, ended Dec 31, 2018 | $2.90B | $845M | $289M |
| FY2019, ended Dec 31, 2019 | $1.75B | $636M | $209M |
| FY2020, ended Dec 31, 2020 | $1.58B | $643M | $256M |
| FY2021, ended Dec 31, 2021 | $546M | $635M | $169M |
| FY2022, ended Dec 31, 2022 | $1.40B | $637M | $309M |
| FY2023, ended Dec 31, 2023 | $1.00B | $766M | $232M |
| FY2024, ended Dec 31, 2024 | $1.15B | $835M | $422M |
| FY2025, ended Dec 31, 2025 | $1.92B | $894M | $408M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.44B | $909M | $304M |
Valuation
At current price- Market Cap
- $197B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.5×
- Price / Book
- 16.7×
- EV / EBITDA
- n/m. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $30.5B
- Revenue Growth YoY
- 5.5%
- Revenue CAGR 3Y
- 2.6%
- Revenue CAGR 5Y
- 3.6%
- EPS Growth YoY
- −153%
- Net Income Growth YoY
- −151%
Profitability
Trailing 12 months- Gross Margin
- 79.6%
- Operating Margin
- −8.2%
- Net Margin
- −10.6%
- FCF Margin
- 42.5%
- Return on Equity
- −20.6%
Earnings
Trailing 12 months- Net Income
- −$3.24B
- EPS (diluted)
- −$2.65
- EBITDA
- −$2.13B
- Operating Income
- −$2.50B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $3.18B
- Total Debt
- $26.2B
- Net Debt
- $23.1B
- Total Assets
- $49.4B
- Total Liabilities
- $37.6B
- Shareholders' Equity
- $11.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.6B
- Capital Expenditure
- $609M
- Free Cash Flow
- $12.9B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $3.25
- Beta (5Y)
- 0.32
Every ratio is calculated from the company’s reported figures.